Ameriprise Financial Inc Mei Pharma, Inc. Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $11,800 - $18,262	-28,096 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $143,284 - $727,034	-265,341 Reduced 90.43%	28,096 $17,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $3.37 $635,262 - $918,813	272,645 Added 1311.3%	293,437 $784,000
Q3 2021 Nov 15, 2021	BUY	$2.52 - $2.99 $52,395 - $62,168	20,792 New	20,792 $57,000
Q2 2018 Aug 14, 2018	SELL	$1.89 - $4.95 $30,865 - $80,838	-16,331 Closed	0 $0

Q1 2018 May 15, 2018	SELL	$2.06 - $2.38 $9,373 - $10,829	-4,550 Reduced 21.79%	16,331 $34,000
Q3 2017 Nov 07, 2017	BUY	$2.44 - $2.91 $50,949 - $60,763	20,881	20,881 $56,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.